what a joke
FDA clarifies the line between wellness and regulated medical devices
By Brian Dolan
January 16, 2015
funds going to sell off clovis and buy azn
AstraZeneca has previously said it believes Tagrisso could generate peak sales of $3 billion a year, making it a key product in the group's growing oncology portfolio.